Use of Race in Pediatric Clinical Practice Guidelines: A Systematic Review

Courtney A Gilliam1, Edwin G Lindo2, Shannon Cannon3

  • 1Division of Hospital Medicine, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle.

JAMA Pediatrics
|June 6, 2022
PubMed

Insights

Pediatric clinical practice guidelines (CPGs) often use race in ways that may worsen health inequities. Medical organizations can improve CPGs to ensure race is used to promote health equity for all children.

Area of Science:

  • Health Equity Research
  • Clinical Practice Guidelines
  • Pediatric Health

Background:

  • National clinical practice guidelines (CPGs) shape medical practice.
  • The inclusion of race in CPGs can impact structural racism and health inequities, both positively and negatively.

Purpose of the Study:

  • To systematically review the utilization of race within published pediatric CPGs.
  • To assess the potential impact of race usage on structural racism and health disparities in pediatric care.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases (PubMed, Medscape, ECRI, MetaLib.gov) for pediatric CPGs published between January 1, 2016, and April 30, 2021.
  • A critical race theory framework was employed to classify the identified uses of race and ethnicity terms based on their potential to affect health inequities.

Main Results:

  • Out of 414 identified pediatric CPGs, 126 (30%) incorporated race or ethnicity terms.
  • Race was mentioned 175 times within CPGs. Of these, 87 instances (49.7%) had a potential negative effect on health inequities, while 50 instances (28.6%) had a potential positive effect.

Conclusions:

  • The review of US-based pediatric CPGs indicates frequent use of race in ways that may exacerbate health care inequities.
  • National medical organizations have significant opportunities to refine the application of race in CPGs to advance health equity, especially for racial and ethnic minority children.
Abstract

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.3K
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
732
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
713
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
766
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
185